Stock RESA RESAPHENE SUISSE AG
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights Resaphene Suisse AG

Equities

RESA

CH0367465439

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Resaphene Suisse AG: FDA Approval Process for Tinnitus Therapy Tinniwell Continues
CI
Resaphene Suisse AG Provides Update on Tinnitus: 4 Phases Until Healing in the Tailor-Made Notched Music Training Discovered with Tinniwell
CI
Resaphene Suisse AG Announces Charité Ethics Committee in Berlin Approves Study on Tinniwell Tinnitus Therapy
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RESA Stock
  4. News Resaphene Suisse AG
  5. Highlights